# Glacier Bancorp, Inc.: financial statements, quarterly

GBCI · NYSE · CIK 868671 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gbci.md) · [Financials](/companies/gbci/financials.md) · [Filings](/companies/gbci/filings.md) · [Insiders](/companies/gbci/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gbci/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [22.7 d](/filings/0000868671-24-000094.md) | [22.6 d](/filings/0000868671-26-000023.md) | [22.2](/filings/0000868671-25-000067.md) | [23.3 d](/filings/0000868671-25-000085.md) | [24.6 d](/filings/0000868671-25-000123.md) | [24.0 d](/filings/0000868671-26-000023.md) | [22.5](/filings/0000868671-26-000053.md) | [24.4 d](/filings/0000868671-26-000069.md) | [25.6 d](/filings/0000868671-25-000123.md) | [28.5 d](/filings/0000868671-26-000023.md) | [26.6](/filings/0000868671-26-000053.md) | [28.4 d](/filings/0000868671-26-000069.md) |
| Interest expense | $m | [97.9](/filings/0000868671-24-000042.md) | [107](/filings/0000868671-24-000042.md) | [113](/filings/0000868671-24-000064.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [11.7](/filings/0000868671-25-000046.md) | [7.8](/filings/0000868671-25-000046.md) | [3.8](/filings/0000868671-25-000067.md) | [9.5](/filings/0000868671-25-000085.md) | [11.2](/filings/0000868671-25-000123.md) | [11.7](/filings/0000868671-25-000046.md) | [8.9](/filings/0000868671-26-000053.md) | [12.4](/filings/0000868671-26-000069.md) | [17.4](/filings/0000868671-25-000123.md) | [12.5 d](/filings/0000868671-26-000023.md) | [18.0](/filings/0000868671-26-000053.md) | [26.6](/filings/0000868671-26-000069.md) |
| Net income | $m | [52.4](/filings/0000868671-25-000046.md) | [54.3](/filings/0000868671-25-000046.md) | [32.6](/filings/0000868671-25-000067.md) | [44.7](/filings/0000868671-25-000085.md) | [51.1](/filings/0000868671-25-000123.md) | [61.8](/filings/0000868671-25-000046.md) | [54.6](/filings/0000868671-26-000053.md) | [52.8](/filings/0000868671-26-000069.md) | [67.9](/filings/0000868671-25-000123.md) | [63.8 d](/filings/0000868671-26-000023.md) | [82.1](/filings/0000868671-26-000053.md) | [97.9](/filings/0000868671-26-000069.md) |
| Diluted EPS | $ per share | [0.47](/filings/0000868671-25-000046.md) | [0.49](/filings/0000868671-25-000046.md) | [0.29](/filings/0000868671-25-000067.md) | [0.39](/filings/0000868671-25-000085.md) | [0.45](/filings/0000868671-25-000123.md) | [0.54](/filings/0000868671-25-000046.md) | [0.48](/filings/0000868671-26-000053.md) | [0.45](/filings/0000868671-26-000069.md) | [0.57](/filings/0000868671-25-000123.md) | not reported | [0.63](/filings/0000868671-26-000053.md) | [0.75](/filings/0000868671-26-000069.md) |
| Basic EPS | $ per share | [0.47](/filings/0000868671-25-000046.md) | [0.49](/filings/0000868671-25-000046.md) | [0.29](/filings/0000868671-25-000067.md) | [0.39](/filings/0000868671-25-000085.md) | [0.45](/filings/0000868671-25-000123.md) | [0.54](/filings/0000868671-25-000046.md) | [0.48](/filings/0000868671-26-000053.md) | [0.45](/filings/0000868671-26-000069.md) | [0.57](/filings/0000868671-25-000123.md) | not reported | [0.63](/filings/0000868671-26-000053.md) | [0.75](/filings/0000868671-26-000069.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [28.1](/filings/0000868671-23-000131.md) | [27.7](/filings/0000868671-25-000046.md) | [27.8](/filings/0000868671-24-000064.md) | [27.8](/filings/0000868671-24-000084.md) | [28.2](/filings/0000868671-24-000094.md) | [27.9](/filings/0000868671-26-000023.md) | [27.9](/filings/0000868671-25-000067.md) | [29.0](/filings/0000868671-25-000085.md) | [29.0](/filings/0000868671-25-000123.md) | [32.0](/filings/0000868671-26-000069.md) | [31.7](/filings/0000868671-26-000053.md) | [31.6](/filings/0000868671-26-000069.md) |
| Total liabilities | $bn | [25.2](/filings/0000868671-23-000131.md) | [24.7](/filings/0000868671-25-000046.md) | [24.7](/filings/0000868671-24-000064.md) | [24.7](/filings/0000868671-24-000084.md) | [25.0](/filings/0000868671-24-000094.md) | [24.7](/filings/0000868671-26-000023.md) | [24.6](/filings/0000868671-25-000067.md) | [25.5](/filings/0000868671-25-000085.md) | [25.4](/filings/0000868671-25-000123.md) | [27.8](/filings/0000868671-26-000069.md) | [27.5](/filings/0000868671-26-000053.md) | [27.3](/filings/0000868671-26-000069.md) |
| Shareholders' equity | $bn | [2.9](/filings/0000868671-24-000094.md) | [3.0](/filings/0000868671-26-000023.md) | [3.1](/filings/0000868671-25-000085.md) | [3.1](/filings/0000868671-25-000123.md) | [3.2](/filings/0000868671-25-000123.md) | [3.2](/filings/0000868671-26-000069.md) | [3.3](/filings/0000868671-26-000069.md) | [3.5](/filings/0000868671-26-000069.md) | [3.6](/filings/0000868671-25-000123.md) | [4.2](/filings/0000868671-26-000069.md) | [4.2](/filings/0000868671-26-000069.md) | [4.3](/filings/0000868671-26-000069.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [130 d](/filings/0000868671-24-000094.md) | [151 d](/filings/0000868671-26-000023.md) | [(56.7)](/filings/0000868671-25-000067.md) | [62.7 d](/filings/0000868671-25-000085.md) | [150 d](/filings/0000868671-25-000123.md) | [102 d](/filings/0000868671-26-000023.md) | [52.4](/filings/0000868671-26-000053.md) | [86.0 d](/filings/0000868671-26-000069.md) | [112 d](/filings/0000868671-25-000123.md) | [123 d](/filings/0000868671-26-000023.md) | [87.9](/filings/0000868671-26-000053.md) | [121 d](/filings/0000868671-26-000069.md) |
| Capital expenditure | $m | not reported | not reported | [6.7](/filings/0000868671-25-000067.md) | [18.5 d](/filings/0000868671-25-000085.md) | [12.4 d](/filings/0000868671-25-000123.md) | [10.7 d](/filings/0000868671-26-000023.md) | [5.7](/filings/0000868671-26-000053.md) | [6.5 d](/filings/0000868671-26-000069.md) | [7.7 d](/filings/0000868671-25-000123.md) | [7.0 d](/filings/0000868671-26-000023.md) | [13.5](/filings/0000868671-26-000053.md) | [9.1 d](/filings/0000868671-26-000069.md) |
| Dividends paid | $m | [36.6 d](/filings/0000868671-24-000094.md) | [73.2 d](/filings/0000868671-26-000023.md) | [0.3](/filings/0000868671-25-000067.md) | [37.4 d](/filings/0000868671-25-000085.md) | [37.4 d](/filings/0000868671-25-000123.md) | [74.9 d](/filings/0000868671-26-000023.md) | [0.4](/filings/0000868671-26-000053.md) | [37.5 d](/filings/0000868671-26-000069.md) | [39.1 d](/filings/0000868671-25-000123.md) | [85.8 d](/filings/0000868671-26-000023.md) | [0.3](/filings/0000868671-26-000053.md) | [42.9 d](/filings/0000868671-26-000069.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [111](/filings/0000868671-23-000131.md) | [111](/filings/0000868671-24-000064.md) | [111](/filings/0000868671-24-000084.md) | [111](/filings/0000868671-24-000094.md) | [113](/filings/0000868671-25-000067.md) | [113](/filings/0000868671-25-000085.md) | [113](/filings/0000868671-25-000123.md) | [114](/filings/0000868671-26-000053.md) | [117](/filings/0000868671-26-000069.md) | [119](/filings/0000868671-25-000123.md) | [130](/filings/0000868671-26-000053.md) | [130](/filings/0000868671-26-000069.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 130,211,953 at 2026-07-16, from the cover of the [10-Q filed 2026-08-04](/filings/0000868671-26-000069.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.